A new review titled "Obesity in Children Aged 2 to 12 Years: A Review" was published in JAMA on October 21, 2026. The publication addresses obesity in children within this age range. Setmelanotide, an approved compound, is referenced within the context of this review. The journal publishing this work is JAMA, a peer reviewed medical publication. This entry reflects only the publication event itself, including its title, journal, and date. No findings, outcomes, or data from the review have been provided alongside this listing. No efficacy or safety conclusions can be drawn from this notice alone. The review is identified by PubMed ID 42905688 for reference purposes. Readers interested in the broader context of setmelanotide as an approved compound can consult additional resources. This brief does not summarize the content, methodology, or conclusions of the review beyond its title and publication details. For more background on setmelanotide, readers can refer to the compound overview.
New JAMA Review Covers Obesity in Children Aged 2 to 12, Mentions Setmelanotide
See the full setmelanotide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42905688/